Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 2, 2014, Pages 258-264

  Khan, Huma ^a   Gupta, Seema ^a   Husain, Nuzhat ^a   Misra, Sanjeev ^b   Singh, Navin ^a   Negi, Mps ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSM Medical University   (India)

^c CSM Medical University   (India)

Author keywords

Chemoradiation; cyclin D1; immunohistochemistry; squamous cell carcinoma

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; TUMOR MARKER;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SECONDARY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84905691989     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.136549     Document Type: Article

References (11)

1. Al-Sarraf M. Treatment of locally advanced head and neck cancer: Historical and critical review. Cancer Control 2002;9:387-99.
2. Gold KA, Kim ES. Role of molecular markers and gene profiling in head and neck cancers. Curr Opin Oncol 2009;21:206-11.
3. Bussink J, van der Kogel AJ, Kaanders JH. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 2008;9:288-96.
4. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996;68:67-108.
5. Motokura T, Arnold A. Cyclin D and oncogenesis. Curr Opin Genet Dev 1993;3:5-10.
6. Musgrove EA. Cyclins: Roles in mitogenic signaling and oncogenic transformation. Growth Factors 2006;24:13-9.
7. Shiraki M, Odajima T, Ikeda T, Sasaki A, Satoh M, Yamaguchi A, et al. Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod Pathol 2005;18:1482-9.
8. Pesuti-Pisac V, Punda A, Glunci I, Bedekovi V, Prani-Kragi A, Kunac N. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: Association with clinicopathological parameters. Croat Med J 2008;49:643-9.
9. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003;2:339-45.
10. Iamaroon A, Krisanaprakornkit S. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma. Oral Oncol 2009;45:E175-9.
11. Schuurbiers OC, Kaanders JH, van der Heijden HF, Dekhuijzen RP, Oyen WJ, Bussink J. The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer. J Thorac Oncol 2009;4:761-7.